ZERIA PHARMACEUTICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,000 JPY | +0.65% |
|
+2.04% | -0.84% |
ETFs positioned on Zeria Pharmaceutical Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.21% | 19 M€ | +11.04% | ||
| 0.02% | 17 M€ | +14.54% | - | |
| 0.01% | 140,441 M€ | +19.56% | ||
| 0.01% | 63,295 M€ | +19.64% | - | |
| 0.01% | 20,360 M€ | +18.38% | - | |
| 0.01% | 746 M€ | -.--% | - | |
| 0.00% | 45 M€ | -.--% | - | |
| 0.00% | 32 M€ | +0.28% | - | |
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 34 M€ | +3.86% | - |
Zeria Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the development of ethical drug business, consumer healthcare business and other business. The Company operates in two business segments. The Ethical Drug segment is engaged in the research, development, manufacture and sale of ethical drugs. The Consumer Healthcare segment is engaged in the manufacture, purchase and sale of over-the-counter (OTC) drugs, health foods, quasi drugs and cosmetics related to self-medication. The others include insurance agency business and real estate business, as well as various maintenance business such as purchasing and sale of promotional materials.
Sector
Pharmaceuticals
Calendar
2024-10-29
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1,987
JPY
Average target price
2,810
JPY
Spread / Average Target
+41.42%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.84% | 557M | |
| +16.10% | 41.97B | |
| +22.56% | 22.34B | |
| +15.93% | 15.25B | |
| +16.36% | 14B | |
| +50.12% | 12.06B | |
| -10.77% | 6.8B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +14.18% | 5.49B |
- Stock Market
- Equities
- 4559 Stock
- Funds and ETFs Zeria Pharmaceutical Co., Ltd.
